Search hospitals > Oklahoma > Lawton
Cancer Centers of Southwest Oklahoma Research
Claim this profileLawton, Oklahoma 73505
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
163 reported clinical trials
25 medical researchers
Summary
Cancer Centers of Southwest Oklahoma Research is a medical facility located in Lawton, Oklahoma. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Cancer Centers of Southwest Oklahoma Research is involved with conducting 163 clinical trials across 317 conditions. There are 25 research doctors associated with this hospital, such as Kathleen Moore, M.D., MS, Raid Aljumaily, Wajeeha Razaq, MD, and Susanna Ulahannan, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Kathleen Moore, M.D., MSUniversity of Oklahoma Health Sciences Center1 year of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
29 reported clinical trials
81 drugs studied
Raid AljumailyUniversity of Oklahoma Health Sciences Center7 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
24 reported clinical trials
40 drugs studied
Wajeeha Razaq, MDUniversity of Oklahoma Health Sciences Center1 year of reported clinical research
Expert in Breast Cancer
Expert in Cancer
24 reported clinical trials
46 drugs studied
Susanna Ulahannan, MDUniversity of Oklahoma Health Sciences Center4 years of reported clinical research
Studies Solid Tumors
Studies Cancer
22 reported clinical trials
43 drugs studied
Clinical Trials running at Cancer Centers of Southwest Oklahoma Research
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Bladder Carcinoma
Diffuse Large B-Cell Lymphoma
Melanoma
Squamous Cell Carcinoma
Renal Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
ARV-471
for Breast Cancer
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Recruiting2 awards Phase 35 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cancer Centers of Southwest Oklahoma Research?
Cancer Centers of Southwest Oklahoma Research is a medical facility located in Lawton, Oklahoma. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Cancer Centers of Southwest Oklahoma Research is involved with conducting 163 clinical trials across 317 conditions. There are 25 research doctors associated with this hospital, such as Kathleen Moore, M.D., MS, Raid Aljumaily, Wajeeha Razaq, MD, and Susanna Ulahannan, MD.